EUVIMEDEUVIMED entdecken
Crossref

Biohacking chronic urticaria: Unlocking the potential of autologous serum therapy

Sampurna Dash, Taru Garg, Vibhu Mendiratta, Rashmi Sarkar

Indian Journal of Skin Allergy · 09.07.2026 · 5 · 162-168

DOI: 10.25259/ijsa_6_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Skin Allergy, online erschienen am 09.07.2026. Verfasst von Sampurna Dash und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Chronic spontaneous urticaria (CSU) affects patients quality of life and psychological well being, necessitating efficient, cost effective treatments that provide sustained relief and reduce pill burden. We aimed to evaluate the effectiveness of adding autologous serum therapy (AST) to standard therapy in uncontrolled CSU by assessing changes in the urticaria activity score (UAS7), urticaria control test (UCT), dermatology life quality index (DLQI), and pill burden index (PBI), while monitoring potential adverse effects. Materials and Methods: This single-centre, open-label, quasi-experimental trial included 50 adult CSU participants randomised into two groups. Group A received daily Tab levocetirizine with weekly AST injections (2 ml fresh serum) for 9 weeks; Group B received Tab levocetirizine only. Antihistamine dosing was individualised, with reduction and escalation permitted based on clinical response to evaluate treatment response and pill burden. Baseline clinical examination, investigations, scoring (UAS7, UCT, DLQI, PBI) along with autologous serum skin test (ASST) was done. Scores were reassessed at weeks 4, 8 and 14. The statistical analysis was done using SPSS analytical software version 26.

Results

Group A showed a rapid and sustained reduction in disease activity, with UAS7 significantly improving by week 4 ( p = 0.004) and persisting post-therapy ( p

Zitieren

APA

Dash, S., Garg, T., Mendiratta, V., & Sarkar, R. (2026). Biohacking chronic urticaria: Unlocking the potential of autologous serum therapy. Indian Journal of Skin Allergy, 5, 162-168. https://doi.org/10.25259/ijsa_6_2026

Vancouver

Dash S, Garg T, Mendiratta V, Sarkar R. Biohacking chronic urticaria: Unlocking the potential of autologous serum therapy. Indian Journal of Skin Allergy. 2026;5:162-168. doi:10.25259/ijsa_6_2026

BibTeX
@article{Dash2026,
  author = {Dash, Sampurna and Garg, Taru and Mendiratta, Vibhu and Sarkar, Rashmi},
  title = {Biohacking chronic urticaria: Unlocking the potential of autologous serum therapy},
  journal = {Indian Journal of Skin Allergy},
  year = {2026},
  volume = {5},
  pages = {162--168},
  doi = {10.25259/ijsa_6_2026}
}
Kostenlos starten →